Grant: Catalyst Grant: Environments, Genes and Chronic Disease
University of Toronto
$100,000.00
Identifying pollutant-sensitive DNA methylation marks associated with a global measure of thrombosis risk: a proof-of-concept study
FY 2013-14
Summary
Venous thromboembolism (VTE) - a blood clot in the vein - affects nearly 64,000 Canadians each year. In nearly 10% of cases, people will die suddenly or before they are diagnosed. These deaths are preventable since the condition can be treated if caught early. We know that exposure to metal pollutants (e.g. mercury, lead, zinc) is associated with VTE and other cardiovascular diseases. We also know that VTE may be caused by a combination of lifestyle, environmental and genetic factors. Although researchers have had some success finding genes and environmental factors involved in the condition, people at risk of VTE are still not well managed and overall understanding of the disease remains poor.
So far, explorations of the genetics of VTE have only looked for variations in the sequence of DNA molecules. New studies, however, can look at not just the order of molecules, but at how DNA molecules are packed, which affects the way they work. These newer studies are called 'epigenetic' studies, 'epi' meaning 'above'. Like DNA sequence, epigenetic marks may be passed from parent to child. But unlike DNA sequence, which is fixed from the moment you are conceived, epigenetics can be changed by your lifestyle or environment, and so make great treatment targets.
Our study will be the first to look at how epigenetics, genetics, and metal pollutants interact to cause VTE. Using data from different cities known for significant exposure to industrial pollution (in Canada, Mexico and France), including both families and unrelated people with and without VTE, we will combine new epigenetic analyses with traditional genetic data, as well as measurements of metal pollutant levels in people's blood. A better understanding of how epigenetics, genetics, and environment work together to cause VTE is vital to prevent, diagnose, and treat this potentially devastating disorder, and may also provide insight into other cardiovascular conditions, such as heart attack and stroke.
Department
Program
Catalyst Grant: Environments, Genes and Chronic Disease
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
285363
Name
Gagnon France
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Catalyst Grant: Environments, Genes and Chronic Disease
Projecttitle
Identifying pollutant-sensitive DNA methylation marks associated with a global measure of thrombosis risk: a proof-of-concept study
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Environments, Genes and Chronic Disease
Keyworddelim
Cardiovascular Diseases; Epigenetics; Ewas; Genetic Epidemiology; Gwas; Hemostatic Proteins; Metalomic Profiles; Methylation; Quantitative Traits; Venous Thromboembolism
Abstract
Venous thromboembolism (VTE) - a blood clot in the vein - affects nearly 64,000 Canadians each year. In nearly 10% of cases, people will die suddenly or before they are diagnosed. These deaths are preventable since the condition can be treated if caught early. We know that exposure to metal pollutants (e.g. mercury, lead, zinc) is associated with VTE and other cardiovascular diseases. We also know that VTE may be caused by a combination of lifestyle, environmental and genetic factors. Although researchers have had some success finding genes and environmental factors involved in the condition, people at risk of VTE are still not well managed and overall understanding of the disease remains poor.
So far, explorations of the genetics of VTE have only looked for variations in the sequence of DNA molecules. New studies, however, can look at not just the order of molecules, but at how DNA molecules are packed, which affects the way they work. These newer studies are called 'epigenetic' studies, 'epi' meaning 'above'. Like DNA sequence, epigenetic marks may be passed from parent to child. But unlike DNA sequence, which is fixed from the moment you are conceived, epigenetics can be changed by your lifestyle or environment, and so make great treatment targets.
Our study will be the first to look at how epigenetics, genetics, and metal pollutants interact to cause VTE. Using data from different cities known for significant exposure to industrial pollution (in Canada, Mexico and France), including both families and unrelated people with and without VTE, we will combine new epigenetic analyses with traditional genetic data, as well as measurements of metal pollutant levels in people's blood. A better understanding of how epigenetics, genetics, and environment work together to cause VTE is vital to prevent, diagnose, and treat this potentially devastating disorder, and may also provide insight into other cardiovascular conditions, such as heart attack and stroke.
Competitiondate
201304
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gagnon, France; Goldenberg, Anna; Wilson, Michael D
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $50,000~ $0~Institute of Genetics~ $50,000~ $0~